Table 2: Post-procedure complications.
| n: 543 | % | ||
| Early complications | 7 | 1.28 | |
| Hemothorax | 0 | 0 | |
| Pneumothorax | 3 | 0.5 | |
| Hematoma | 3 | 0.5 | |
| Catheter migration | 1 | 0.18 | |
| Late complications | 41 | 7.55 | |
| Catheter-associated infection | 14 | 2.5 | |
| Catheter dysfunction | 6 | 1.2 | |
| Catheter-reservoir disconnection | 1 | 0.18 | |
| Septic embolism | 1 | 0.01 | |
| Reservoir torsion | 4 | 0.7 | |
| Skin erosion | 11 | 2.0 | |
| Venous thrombosis | 4 | 0.7 | |
| Complications by intervention site | |||
| Right | 35 | 6.4 | |
| Left | 13 | 2.3 | |
| Complications by gender | |||
| Male | 21 | 3.8 | |
| Female | 27 | 4.9 | |
| Complications by catheter brand | |||
| Celsite catheter* | 34 | 6.2 | |
| Bard catheter** | 14 | 2.5 | |
| Total complications | 48 | 8.8 | |
| Mortality | 0 | 0 | |
*Celsite® ST301V, B. Braun Medical, Boulogne Cedex, France); **Bard catheters (Bard, Utah, USA)